National Institutes of Health, Laboratory of Metabolism, National Cancer Institute, Center for Cancer Research, Bethesda , USA
Fei Li completed his PH.D. in pharmacognosy from School of Pharmaceutical Science in Peking University at 2008. After that, he joined the Laboratory of Metabolism Research in NIH at 2011. Currently, he is one senior fellow of mass spectrometry-based metabolomics in Center for Cancer Research of NCI, Bethesda. Dr. Li has won the NIH Fellows Award for Research Excellence (FARE) at 2011. He is the membership of American Society of Pharmacology and Experimental Therapeutics (ASPET), Metabolomics Society, and OMICS Group. He also serves on the editorial boards of Journal of Drug Metabolism & Toxicity. Dr. Li have authored more than 40 internal journal articles and meeting presentations.
Metabolism, toxicity, and carcinogenicity of drugs and chemicals Metabolic profiling of drug efficacy and toxicity Identification of biomarkers for diseases using mass spectrometry based-metabolomics ADME/DMPK